[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

China Nasal Polyposis Drug Market Research Report 2018

March 2018 | 101 pages | ID: CFDA1D609FEEN
QYResearch

US$ 3,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Nasal Polyposis Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Nasal Polyposis Drug development status and future trend in China, focuses on top players in China, also splits Nasal Polyposis Drug by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
  • Allakos Inc
  • Cumberland Pharmaceuticals Inc
  • F. Hoffmann-La Roche Ltd
  • OptiNose US Inc
  • Regeneron Pharmaceuticals Inc
Geographically, this report splits the China market into six regions,
  • South China
  • East China
  • Southwest China
  • Northeast China
  • North China
  • Central China
  • Northwest China
On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
  • AK-001
  • Dupilumab
  • Fluticasone Propionate
  • Ifetroban Sodium
  • Omalizumab
  • Others
On the basis of the end users/application, this report covers
  • Hospital
  • Clinic
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
China Nasal Polyposis Drug Market Research Report 2018

1 NASAL POLYPOSIS DRUG OVERVIEW

1.1 Product Overview and Scope of Nasal Polyposis Drug
1.2 Classification of Nasal Polyposis Drug by Product Category
  1.2.1 China Nasal Polyposis Drug Sales (K Pcs) Comparison by Type (2013-2025)
  1.2.2 China Nasal Polyposis Drug Sales (K Pcs) Market Share by Type in 2017
  1.2.3 AK-001
  1.2.4 Dupilumab
  1.2.5 Fluticasone Propionate
  1.2.6 Ifetroban Sodium
  1.2.7 Omalizumab
  1.2.8 Others
1.3 China Nasal Polyposis Drug Market by Application/End Users
  1.3.1 China Nasal Polyposis Drug Sales (K Pcs) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 China Nasal Polyposis Drug Market by Region
  1.4.1 China Nasal Polyposis Drug Market Size (Million USD) Comparison by Region (2013-2025)
  1.4.2 South China Nasal Polyposis Drug Status and Prospect (2013-2025)
  1.4.3 East China Nasal Polyposis Drug Status and Prospect (2013-2025)
  1.4.4 Southwest China Nasal Polyposis Drug Status and Prospect (2013-2025)
  1.4.5 Northeast China Nasal Polyposis Drug Status and Prospect (2013-2025)
  1.4.6 North China Nasal Polyposis Drug Status and Prospect (2013-2025)
  1.4.7 Central China Nasal Polyposis Drug Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Nasal Polyposis Drug (2013-2025)
  1.5.1 China Nasal Polyposis Drug Sales (K Pcs) and Growth Rate (%)(2013-2025)
  1.5.2 China Nasal Polyposis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 CHINA NASAL POLYPOSIS DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Nasal Polyposis Drug Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Nasal Polyposis Drug Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Nasal Polyposis Drug Average Price (USD/Pcs) by Players/Manufacturers (2013-2018)
2.4 China Nasal Polyposis Drug Market Competitive Situation and Trends
  2.4.1 China Nasal Polyposis Drug Market Concentration Rate
  2.4.2 China Nasal Polyposis Drug Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Nasal Polyposis Drug Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA NASAL POLYPOSIS DRUG SALES AND REVENUE BY REGION (2013-2018)

3.1 China Nasal Polyposis Drug Sales (K Pcs) and Market Share by Region (2013-2018)
3.2 China Nasal Polyposis Drug Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Nasal Polyposis Drug Price (USD/Pcs) by Regions (2013-2018)

4 CHINA NASAL POLYPOSIS DRUG SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2013-2018)

4.1 China Nasal Polyposis Drug Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018)
4.2 China Nasal Polyposis Drug Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Nasal Polyposis Drug Price (USD/Pcs) by Type (2013-2018)
4.4 China Nasal Polyposis Drug Sales Growth Rate (%) by Type (2013-2018)

5 CHINA NASAL POLYPOSIS DRUG SALES BY APPLICATION (2013-2018)

5.1 China Nasal Polyposis Drug Sales (K Pcs) and Market Share by Application (2013-2018)
5.2 China Nasal Polyposis Drug Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 CHINA NASAL POLYPOSIS DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Allakos Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Nasal Polyposis Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Allakos Inc Nasal Polyposis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Cumberland Pharmaceuticals Inc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Nasal Polyposis Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Cumberland Pharmaceuticals Inc Nasal Polyposis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.2.4 Main Business/Business Overview
6.3 F. Hoffmann-La Roche Ltd
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Nasal Polyposis Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 F. Hoffmann-La Roche Ltd Nasal Polyposis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.3.4 Main Business/Business Overview
6.4 OptiNose US Inc
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Nasal Polyposis Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 OptiNose US Inc Nasal Polyposis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Regeneron Pharmaceuticals Inc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Nasal Polyposis Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Regeneron Pharmaceuticals Inc Nasal Polyposis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.5.4 Main Business/Business Overview

7 NASAL POLYPOSIS DRUG MANUFACTURING COST ANALYSIS

7.1 Nasal Polyposis Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nasal Polyposis Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nasal Polyposis Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nasal Polyposis Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA NASAL POLYPOSIS DRUG MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

11.1 China Nasal Polyposis Drug Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025)
11.2 China Nasal Polyposis Drug Sales (K Pcs) Forecast by Type (2018-2025)
11.3 China Nasal Polyposis Drug Sales (K Pcs) Forecast by Application (2018-2025)
11.4 China Nasal Polyposis Drug Sales (K Pcs) Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Nasal Polyposis Drug Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Nasal Polyposis Drug Sales (K Pcs) by Application (2013-2025)
Figure Product Picture of Nasal Polyposis Drug
Table China Nasal Polyposis Drug Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Nasal Polyposis Drug Sales Volume Market Share by Types in 2017
Figure AK-001 Product Picture
Figure Dupilumab Product Picture
Figure Fluticasone Propionate Product Picture
Figure Ifetroban Sodium Product Picture
Figure Omalizumab Product Picture
Figure Others Product Picture
Figure China Nasal Polyposis Drug Sales (K Pcs) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Nasal Polyposis Drug by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Nasal Polyposis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Nasal Polyposis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Nasal Polyposis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Nasal Polyposis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Nasal Polyposis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Nasal Polyposis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Nasal Polyposis Drug Sales (K Pcs) and Growth Rate (%)(2013-2025)
Figure China Nasal Polyposis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Nasal Polyposis Drug Sales of Key Players/Manufacturers (2013-2018)
Table China Nasal Polyposis Drug Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Nasal Polyposis Drug Sales Share (%) by Players/Manufacturers
Figure 2017 China Nasal Polyposis Drug Sales Share (%) by Players/Manufacturers
Table China Nasal Polyposis Drug Revenue by Players/Manufacturers (2013-2018)
Table China Nasal Polyposis Drug Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Nasal Polyposis Drug Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Nasal Polyposis Drug Revenue Market Share (%) by Players/Manufacturers
Table China Market Nasal Polyposis Drug Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Nasal Polyposis Drug Average Price of Key Players/Manufacturers in 2017
Figure China Nasal Polyposis Drug Market Share of Top 3 Players/Manufacturers
Figure China Nasal Polyposis Drug Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Nasal Polyposis Drug Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Nasal Polyposis Drug Product Category
Table China Nasal Polyposis Drug Sales (K Pcs) by Regions (2013-2018)
Table China Nasal Polyposis Drug Sales Share (%) by Regions (2013-2018)
Figure China Nasal Polyposis Drug Sales Share (%) by Regions (2013-2018)
Figure China Nasal Polyposis Drug Sales Market Share (%) by Regions in 2017
Table China Nasal Polyposis Drug Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Nasal Polyposis Drug Revenue Market Share (%) by Regions (2013-2018)
Figure China Nasal Polyposis Drug Revenue Market Share (%) by Regions (2013-2018)
Figure China Nasal Polyposis Drug Revenue Market Share (%) by Regions in 2017
Table China Nasal Polyposis Drug Price (USD/Pcs) by Regions (2013-2018)
Table China Nasal Polyposis Drug Sales (K Pcs) by Type (2013-2018)
Table China Nasal Polyposis Drug Sales Share (%) by Type (2013-2018)
Figure China Nasal Polyposis Drug Sales Share (%) by Type (2013-2018)
Figure China Nasal Polyposis Drug Sales Market Share (%) by Type in 2017
Table China Nasal Polyposis Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Nasal Polyposis Drug Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Nasal Polyposis Drug by Type (2013-2018)
Figure Revenue Market Share of Nasal Polyposis Drug by Type in 2017
Table China Nasal Polyposis Drug Price (USD/Pcs) by Types (2013-2018)
Figure China Nasal Polyposis Drug Sales Growth Rate (%) by Type (2013-2018)
Table China Nasal Polyposis Drug Sales (K Pcs) by Applications (2013-2018)
Table China Nasal Polyposis Drug Sales Market Share (%) by Applications (2013-2018)
Figure China Nasal Polyposis Drug Sales Market Share (%) by Application (2013-2018)
Figure China Nasal Polyposis Drug Sales Market Share (%) by Application in 2017
Table China Nasal Polyposis Drug Sales Growth Rate (%) by Application (2013-2018)
Figure China Nasal Polyposis Drug Sales Growth Rate (%) by Application (2013-2018)
Table Allakos Inc Nasal Polyposis Drug Basic Information List
Table Allakos Inc Nasal Polyposis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Allakos Inc Nasal Polyposis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Allakos Inc Nasal Polyposis Drug Sales Market Share (%) in China (2013-2018)
Figure Allakos Inc Nasal Polyposis Drug Revenue Market Share (%) in China (2013-2018)
Table Cumberland Pharmaceuticals Inc Nasal Polyposis Drug Basic Information List
Table Cumberland Pharmaceuticals Inc Nasal Polyposis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Cumberland Pharmaceuticals Inc Nasal Polyposis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Cumberland Pharmaceuticals Inc Nasal Polyposis Drug Sales Market Share (%) in China (2013-2018)
Figure Cumberland Pharmaceuticals Inc Nasal Polyposis Drug Revenue Market Share (%) in China (2013-2018)
Table F. Hoffmann-La Roche Ltd Nasal Polyposis Drug Basic Information List
Table F. Hoffmann-La Roche Ltd Nasal Polyposis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure F. Hoffmann-La Roche Ltd Nasal Polyposis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure F. Hoffmann-La Roche Ltd Nasal Polyposis Drug Sales Market Share (%) in China (2013-2018)
Figure F. Hoffmann-La Roche Ltd Nasal Polyposis Drug Revenue Market Share (%) in China (2013-2018)
Table OptiNose US Inc Nasal Polyposis Drug Basic Information List
Table OptiNose US Inc Nasal Polyposis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure OptiNose US Inc Nasal Polyposis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure OptiNose US Inc Nasal Polyposis Drug Sales Market Share (%) in China (2013-2018)
Figure OptiNose US Inc Nasal Polyposis Drug Revenue Market Share (%) in China (2013-2018)
Table Regeneron Pharmaceuticals Inc Nasal Polyposis Drug Basic Information List
Table Regeneron Pharmaceuticals Inc Nasal Polyposis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Regeneron Pharmaceuticals Inc Nasal Polyposis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Regeneron Pharmaceuticals Inc Nasal Polyposis Drug Sales Market Share (%) in China (2013-2018)
Figure Regeneron Pharmaceuticals Inc Nasal Polyposis Drug Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nasal Polyposis Drug
Figure Manufacturing Process Analysis of Nasal Polyposis Drug
Figure Nasal Polyposis Drug Industrial Chain Analysis
Table Raw Materials Sources of Nasal Polyposis Drug Major Players/Manufacturers in 2017
Table Major Buyers of Nasal Polyposis Drug
Table Distributors/Traders List
Figure China Nasal Polyposis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure China Nasal Polyposis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Nasal Polyposis Drug Price (USD/Pcs) Trend Forecast (2018-2025)
Table China Nasal Polyposis Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure China Nasal Polyposis Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure China Nasal Polyposis Drug Sales Volume Market Share Forecast by Type in 2025
Table China Nasal Polyposis Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure China Nasal Polyposis Drug Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Nasal Polyposis Drug Sales Volume Market Share Forecast by Application in 2025
Table China Nasal Polyposis Drug Sales (K Pcs) Forecast by Regions (2018-2025)
Table China Nasal Polyposis Drug Sales Volume Share Forecast by Regions (2018-2025)
Figure China Nasal Polyposis Drug Sales Volume Share Forecast by Regions (2018-2025)
Figure China Nasal Polyposis Drug Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories